India to Mauritius Pharmaceutical Export
Bilateral Trade Intelligence · $85.3M Total Trade · 308 Exporters · 405 Buyers · DGFT Verified · Updated March 2026
India exported $85.3M worth of pharmaceutical formulations to Mauritius across 45,848 verified shipments, sourced from 308 Indian exporters supplying 405 Mauritius buyers. The top exporters are IPCA LABORATORIES LIMITED ($11.2M) and SAVA HEALTHCARE LIMITED ($10.6M). The leading products are Insulin ($609K) and Apixaban ($339K). Average shipment value: $1.9K.
Top Pharmaceutical Formulations — India to Mauritius
| # | Formulation | Value | Share |
|---|---|---|---|
| 1 | Ophthalmic Medicaments-a-indomecin Eye D | $5.0M | 5.9% |
| 2 | Harmless Medicines: Zerodol Plus Tablets(aceclofenac 100mg + Paracetamol 500mg) | $3.0M | 3.5% |
| 3 | Harmless Medicines: Celedol 200mg Capsules (celecoxib) [ 's Per Pack] | $1.9M | 2.2% |
| 4 | Harmless Medicines: Hcqs 200mg Tablets | $1.1M | 1.3% |
| 5 | Ivermectol 12mg 48tab Ivermectin | $934.7K | 1.1% |
| 6 | Harmless Medicines: Clopica 75mg Tablets | $792.5K | 0.9% |
| 7 | Abacavir Sulfate 300mg Tablets (60s) (1000 Packs X60s=60000 ) | $720.0K | 0.8% |
| 8 | Biosulin 30/70 Insulin Injection.biphasic Isop | $609.3K | 0.7% |
| 9 | Harmless Medicines: Glycinorm Lp 60mg Tablets (gliclazide) | $550.5K | 0.6% |
| 10 | Cresar Am Tablets (mu) Alu-alu 3x10's [3200 X3x10's] | $529.0K | 0.6% |
| 11 | Harmless Medicines: Pantonex Dr-40mg Tablets [pantoprazole] | $492.9K | 0.6% |
| 12 | Harmless Medicines: Quel Sr-100mg Tablets (quetiapine) | $452.5K | 0.5% |
| 13 | Harmless Medicines: Tenolol-50mg Tablets(atenolol) | $395.8K | 0.5% |
| 14 | Harmless Medicines: Quel Sr-300mg Tablets (quetiapine) | $371.4K | 0.4% |
| 15 | Eliquis 5 Tablets (apixaban/5mg) | $338.7K | 0.4% |
India exports 20+ pharmaceutical formulations to Mauritius with a combined trade value of $85.3M. Key products include Insulin ($609K), Apixaban ($339K). These are finished dosage forms — tablets, capsules, injectables, and combination drugs — shipped from Indian manufacturing facilities with FDA, WHO-GMP, and EU GMP certifications. Data from 45,848 verified Indian Customs (DGFT) shipment records.
Top Pharmaceutical Products — India to Mauritius Trade Routes
These are the top pharmaceutical products exported from India to Mauritius, each with a dedicated trade route analysis page. Click any product to see detailed export data including Indian suppliers, Mauritius buyers, regulatory requirements, and logistics for that specific product corridor. Products include Insulin ($609K), Apixaban ($339K) — all finished pharmaceutical formulations verified from Indian Customs (DGFT) records.
Top Indian Exporters to Mauritius
308 Indian pharmaceutical companies export finished formulations to Mauritius. Leading exporters include Ipca Laboratories Limited, Sava Healthcare Limited, Appasamy Associates Private Limited, Msn Laboratories Private Limited. The top exporter accounts for 13.1% of total India–Mauritius pharma exports. Source: Indian Customs (DGFT).
Top Mauritius Buyers from India
405 companies in Mauritius import pharmaceutical formulations from India. Top buyers include Regency Pharma Limited, The Mauritius Pharmacy (seegobin) L, Expiation International Ltd, Msj Limited (unicorn). The largest buyer accounts for 13.3% of India–Mauritius pharma imports. Source: Indian Customs (DGFT).
Port Analysis — India to Mauritius Pharmaceutical Shipments
Indian Export Ports
Mauritius Import Ports
Trade Statistics
Other Destinations
Product Routes
FAQ — India to Mauritius Pharmaceutical Trade
What is the total value of India's pharmaceutical export to Mauritius?
India exported pharmaceuticals worth $85.3M to Mauritius across 45,848 verified shipments.
Who are the top Indian pharmaceutical exporters to Mauritius?
1. IPCA LABORATORIES LIMITED — $11.2M. 2. SAVA HEALTHCARE LIMITED — $10.6M. 3. APPASAMY ASSOCIATES PRIVATE LIMITED — $5.6M. Total: 308 suppliers.
Which companies in Mauritius import pharmaceuticals from India?
1. REGENCY PHARMA LIMITED — $11.3M. 2. THE MAURITIUS PHARMACY (SEEGOBIN) L — $6.6M. 3. EXPIATION INTERNATIONAL LTD — $5.6M. 405 buyers total.
What pharmaceutical products does India export most to Mauritius?
1. Ophthalmic Medicaments-a-indomecin Eye D ($5.0M, 5.9%); 2. Harmless Medicines: Zerodol Plus Tablets(aceclofenac 100mg + Paracetamol 500mg) ($3.0M, 3.5%); 3. Harmless Medicines: Celedol 200mg Capsules (celecoxib) [ 's Per Pack] ($1.9M, 2.2%); 4. Harmless Medicines: Hcqs 200mg Tablets ($1.1M, 1.3%); 5. Ivermectol 12mg 48tab Ivermectin ($934.7K, 1.1%)
Which ports handle pharmaceutical shipments from India to Mauritius?
Export: SAHAR AIR, SAHAR AIR CARGO ACC (INBOM4), NHAVA SHEVA SEA (INNSA1), CHENNAI AIR, DELHI AIR. Import: MAURITIUS, Port Louis, PORT LOUIS, Sir Seewoosagur Ramg, ST LOUIS.
Why does Mauritius import pharmaceuticals from India?
India's cost-competitive generic drug manufacturing, WHO-GMP certified facilities, and broad product portfolio. This $85.3M corridor reflects quality compliance and pricing advantages.
What certifications do Indian pharmaceutical exporters need to supply Mauritius?
WHO-GMP certification, EU GMP approval (for EU markets), product dossier registration (CTD format), and ICH guideline compliance.
What is the average shipment value for India to Mauritius pharmaceutical trade?
$1.9K per consignment across 45,848 shipments.
How many Indian pharmaceutical companies export to Mauritius?
308 Indian companies. Largest: IPCA LABORATORIES LIMITED with $11.2M.
How can I find verified Indian pharmaceutical suppliers for Mauritius?
TransData Nexus covers 308 active exporters with shipment history and trade values at transdatanexus.com.
Unlock the Full India to Mauritius Pharmaceutical Export Dataset
Access complete shipment records, supplier intelligence, buyer histories, and price analytics for all 45,848 shipments.
Official References & Regulatory Resources
- WHO Essential Medicines List
- CDSCO India
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Data Source: Indian Customs (DGFT) export shipping bill records covering all pharmaceutical shipments from India.
- 2.Country Matching: Shipments to Mauritius identified using destination country codes from customs declarations.
- 3.Statistical Normalization: Values are statistically normalized to remove outlier transactions and ensure accurate market share representation.
- 4.Coverage: 45,848 verified shipments from 308 Indian exporters to 405 Mauritius buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
308 Exporters
405 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists